Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
Nekesha Oliphant MD
Nekesha Oliphant MD Advisory Board
Peter Lin MD, CCFP
Peter Lin MD, CCFP Associate Editor
See All Experts
featured
Published in Primary Care and
2 other channels

Journal Scan / Research · February 17, 2022

Safety of Concomitant Flu and SARS-CoV-2 Vaccine Booster in Older Adults

The Lancet Respiratory Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Morgan Soffler MD

Jonathan Temte MD, PhD

The Lancet Respiratory Medicine
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
Lancet Respir Med 2022 Jan 31;[EPub Ahead of Print], R Izikson, D Brune, J-S Bolduc, P Bourron, et al

Further Reading

Most Read This Week

Recently Updated